Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7330
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study ; day:15 ; month:7 ; year:2020 ; pages:1-12
Journal of assisted reproduction and genetics ; (15.7.2020), 1-12
- Urheber
-
Carosso, Andrea
Revelli, Alberto
Gennarelli, Gianluca
Canosa, Stefano
Cosma, Stefano
Borella, Fulvio
Tancredi, Annalisa
Paschero, Carlotta
Boatti, Lara
Zanotto, Elisa
Sidoti, Francesca
Bottino, Paolo
Costa, Cristina
Cavallo, Rossana
Benedetto, Chiara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10815-020-01878-4
- URN
-
urn:nbn:de:101:1-2020091123571753961813
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carosso, Andrea
- Revelli, Alberto
- Gennarelli, Gianluca
- Canosa, Stefano
- Cosma, Stefano
- Borella, Fulvio
- Tancredi, Annalisa
- Paschero, Carlotta
- Boatti, Lara
- Zanotto, Elisa
- Sidoti, Francesca
- Bottino, Paolo
- Costa, Cristina
- Cavallo, Rossana
- Benedetto, Chiara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differential characteristics of vaginal versus endometrial microbiota in IVF patients
Endometrial progesterone resistance and PCOS
The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis
Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial
Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial
Smoking Decreases Endometrial Thickness in IVF/ICSI Patients
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
The association of maternal vaginal bleeding and progesterone supplementation in early pregnancy with offspring outcomes: a prospective cohort study
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
Endometrial Receptivity and its Predictive Value for IVF/ICSI-Outcome
A functional role of LEFTY during progesterone therapy for endometrial carcinoma
Differential characteristics of vaginal versus endometrial microbiota in IVF patients
Endometrial progesterone resistance and PCOS
The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis
Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial
Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial
Smoking Decreases Endometrial Thickness in IVF/ICSI Patients
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
The association of maternal vaginal bleeding and progesterone supplementation in early pregnancy with offspring outcomes: a prospective cohort study
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
Endometrial Receptivity and its Predictive Value for IVF/ICSI-Outcome
A functional role of LEFTY during progesterone therapy for endometrial carcinoma
Differential characteristics of vaginal versus endometrial microbiota in IVF patients
Endometrial progesterone resistance and PCOS
The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis
Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial
Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial
Smoking Decreases Endometrial Thickness in IVF/ICSI Patients
Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support
The association of maternal vaginal bleeding and progesterone supplementation in early pregnancy with offspring outcomes: a prospective cohort study
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk
Endometrial Receptivity and its Predictive Value for IVF/ICSI-Outcome